Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | IDT | CHCO |
|---|---|---|
| Price | $80.08 | $141.77 |
| Change today | ▲ 1.48% | ▼ 0.74% |
| Market cap | $1.99B | $1.99B |
| Return, 3 months | +31.2% | +7.5% |
| Return, year to date | +56.9% | +21.4% |
| Return, 1 year | +65.8% | +17.9% |
| P/E (TTM) | 23.1 | 15.5 |
| P/B | 5.3 | 2.5 |
| P/E percentile vs own 5y | 81st | – |
| Dividend yield | 0.32% | 2.40% |
| Revenue growth (YoY, latest qtr) | – | +7.1% |
| Net profit growth (YoY) | – | +11.4% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | 41.7% |
| Return on equity | – | 16.6% |
| Analyst target vs. price | +6.1% | +2.3% |
| Analyst buy share | 100% | 0% |
| RSI (14) | 77 | 49 |
| 30-day volatility | 33.5% | 13.0% |
| Max drawdown, 1 year | -29.3% | -8.8% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
